Abstract
An experiment was conducted to assess the effect of soybean agglutinin dosage level on growth, body composition, plasma lipids, glucose, urea nitrogen content and aminotransferase activities in rats. Male and female rats (n = 60) weaned at 19 d were given a dose of 0, 3.5, 7.0, 10.5, or 14.0 mg soybean agglutinin by gastric infusion once daily for 10 days. With increasing doses of soybean agglutinin, body weight, lipid content of carcass, spleen and kidneys relative dry weights decreased, while small intestine and pancreatic weight, the contents of urea nitrogen and triglyceride, and the activities of aspartate aminotransferase linearly increased in plasma. Though soybean agglutinin decreased plasma insulin content, changes in plasma glucose content due to soybean agglutinin were not detected. It is suggested that dietary soybean agglutinin may affect the secretion of other hormones besides insulin, which modulate blood glucose reserves. In conclusion, consumption of soybean agglutinin resulted in a depletion of lipid and an overgrowth of small intestine and pancreas in rats. Meanwhile, poor growth of spleen and kidneys was observed in the soybean agglutinin-fed rats.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
